DR. JOHN C BLANKENSHIP NPI 1730160177

NPI Details

DR. John C Blankenship is a specialist in Athens, GA with 25 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. John C Blankenship NPI is 1730160177. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

195 KING AVE.
ATHENS, GA
ZIP 30606
Phone: (706) 543-6261
Fax: (706) 543-7060

The NPI 1730160177 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, propofol, 10 mg (HCPCS:J2704)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Automated urinalysis test (HCPCS:81003)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Injection, fentanyl citrate, 0.1 mg (HCPCS:J3010)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes (HCPCS:99153)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Biopsy of prostate gland (HCPCS:55700)
• Insertion of tube into ureter using an endoscope through bladder area (HCPCS:52005)
• Biopsy of bladder using an endoscope (HCPCS:52204)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Injection procedure to cause erection (HCPCS:54235)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 11/11/2005 and was last updated on 11/5/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.